VWA
BIIB icon

Valued Wealth Advisors’s Biogen BIIB Stock Holding History

Valued Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1
Closed -$126 – 630
2025
Q2 		$126 Hold
1
– – ﹤0.01% 598
2025
Q1 		$137 Sell
1
-2
-67% -$286 ﹤0.01% 628
2024
Q4 		$459 Sell
3
-5
-63% -$843 ﹤0.01% 555
2024
Q3 		$1.55K Hold
8
– – ﹤0.01% 398
2024
Q2 		$1.85K Sell
8
-7
-47% -$1.52K ﹤0.01% 371
2024
Q1 		$3.23K Buy
15
+7
+88% +$1.64K ﹤0.01% 294
2023
Q4 		$2.06K Buy
+8
New +$1.97K ﹤0.01% 301

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Valued Wealth Advisors's BIIB Position: Q3 2025 in Review

Valued Wealth Advisors sold out of Biogen (BIIB) in Q3 2025, closing a stake of 1 share — an estimated $126 sold.

Valued Wealth Advisors first reported a position in BIIB in Q4 2023 and held it in 7 quarters. The position peaked at $3.23K in Q1 2024. 907 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.

  • Valued Wealth Advisors reported no remaining Biogen position as of Q3 2025 after selling out during the quarter.
  • Valued Wealth Advisors sold 1 Biogen share in Q3 2025, an estimated $126.
  • Valued Wealth Advisors first reported a position in Biogen in Q4 2023 and held it in 7 quarters.
  • Valued Wealth Advisors's Biogen position peaked at $3.23K in Q1 2024.
  • 907 funds tracked by Wall St. Rank held Biogen as of Q3 2025.

Based on Valued Wealth Advisors's 13F filing for Q3 2025, filed 29 Oct 2025.